Analyst Ratings for Trevi Therapeutics (TRVI)
TRVI Rating Summary
TRVI Price Target Summary
- Highest: $25.00 (Cantor Fitzgerald)
- Lowest: $16.00 (B.Riley)
- Average: $20.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.75 (+56%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$20.75 (+56%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/13/2025 | Leerink Partners » Updated 2/2/2026 |
Roanna Ruiz | New Coverage | Outperform (N/A) |
21.00 (16.00) |
11.85 (13.30) |
12.24% | Details |
| 8/21/2025 | Morgan Stanley » Updated 11/14/2025 |
Judah Frommer | New Coverage | Overweight (N/A) |
19.00 (18.00) |
7.32 (13.30) |
81.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
